Drug interactions and hepatitis produced by some macrolide antibiotics
about
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classesLack of pharmacokinetic interaction between tiagabine and erythromycin.Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycinInteraction between erythromycin and nitrazepam in healthy volunteers.The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions.Use of in vitro transporter assays to understand hepatic and renal disposition of new drug candidates.Central role of mitochondria in drug-induced liver injury.Antibiotic induced liver injury: what about children?Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis.International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.The Role of Macrolides in Chronic Rhinosinusitis (CRSsNP and CRSwNP).Erythromycin base-induced rash and liver function disturbances.Macrolides versus azalides: a drug interaction update.No effect of roxithromycin on pharmacokinetic or pharmacodynamic properties of warfarin and its enantiomers.Paranoia erotica (Clerambault syndrome) successfully treated with risperidone.Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions.Effects of embelin on lipid peroxidation and free radical scavenging activity against liver damage in rats.Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepam.Erythromycin-induced genotoxicity and hepatotoxicity in mice pups treated during prenatal and postnatal period.
P2860
Q28243911-8D2A2881-30A2-4884-8690-CA665C932664Q33488034-EF096659-C368-4388-847F-3DB9022EB0F4Q34049823-A378BA0B-2FEC-4139-A6AA-1F044A448C98Q34300475-68DF4A6B-425D-4C70-ADCC-9CE842F29F31Q34586375-BC2346B7-8672-4585-B2AB-56DDAD7E6274Q36544962-0B964544-B1F9-4E0D-A4DC-F1207905F1C9Q37926590-A75725AF-B945-4124-9DB8-32068144FB20Q38144140-2EA42EFC-7D8C-463E-A7D2-107F477C8FD4Q38178836-820C758D-AAB4-4E03-B14B-E700A170A062Q38738551-074664FF-C5B6-4BA7-9D6B-D34630125568Q39254062-BB9201BE-9117-4922-9D88-842EA8B67EB8Q40726213-9F4074FA-E6AF-409A-8CBB-856B9E8CC1D7Q40938716-9C1FF5C2-A2D8-4F79-A2E4-A324428506D4Q44079429-DB0E982C-2E7E-46A2-AAC8-E0E654CC9CD4Q44229951-65A9E2DE-B405-4879-B84D-2A3BBD0BA109Q45069532-42FEAFAC-A28E-4617-B66F-4F7455D5BF31Q45982767-9EE2B00C-BBF0-4EAC-B228-CB86E9BAE70CQ51578319-F9EB0C80-383D-4CA0-88D8-8CA28BCB71F3Q54778202-673A6055-52B3-413E-95A4-4C08B1E54846
P2860
Drug interactions and hepatitis produced by some macrolide antibiotics
description
im Juli 1985 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 July 1985
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1985
@uk
name
Drug interactions and hepatitis produced by some macrolide antibiotics
@en
Drug interactions and hepatitis produced by some macrolide antibiotics
@nl
type
label
Drug interactions and hepatitis produced by some macrolide antibiotics
@en
Drug interactions and hepatitis produced by some macrolide antibiotics
@nl
prefLabel
Drug interactions and hepatitis produced by some macrolide antibiotics
@en
Drug interactions and hepatitis produced by some macrolide antibiotics
@nl
P2093
P356
P1476
Drug interactions and hepatitis produced by some macrolide antibiotics
@en
P2093
D Pessayre
J P Benhamou
P304
P356
10.1093/JAC/16.SUPPL_A.181
P407
P433
P478
16 Suppl A
P577
1985-07-01T00:00:00Z